OKUR

OnKure Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD4.20

-0.02 (-0.47%)

Rating:B

Company Profile

CEO

Nicholas A. Saccomano

IPO Date

2021-04-08

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$4.11

Prev. Close

$4.22

Day Low

$4.04

Day High

$4.40

52W Low

$1.91

52W High

$5.38

Market Cap

$0.06B

Volume

0.33M

Price Chart

No price data available.

About

OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors. The company was incorporated in 2011 and is based in Boulder, Colorado.

https://onkuretherapeutics.com

Price Performance

1 Day

-0.47%

5 Days

+1.94%

1 Month

-8.70%

3 Months